Nextage Therapeutics (Israel) Price Prediction
| NXTG Stock | ILA 67.70 1.70 2.45% |
Oversold Vs Overbought
63
Oversold | Overbought |
Using Nextage Therapeutics hype-based prediction, you can estimate the value of Nextage Therapeutics from the perspective of Nextage Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Nextage Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Nextage because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Nextage Therapeutics after-hype prediction price | ILA 67.7 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Nextage |
Nextage Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Nextage Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nextage Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Nextage Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Nextage Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Nextage Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nextage Therapeutics' historical news coverage. Nextage Therapeutics' after-hype downside and upside margins for the prediction period are 63.26 and 72.14, respectively. We have considered Nextage Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Nextage Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Nextage Therapeutics is based on 3 months time horizon.
Nextage Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Nextage Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nextage Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nextage Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.12 | 4.44 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
67.70 | 67.70 | 0.00 |
|
Nextage Therapeutics Hype Timeline
Nextage Therapeutics is now traded for 67.70on Tel Aviv Stock Exchange of Israel. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Nextage is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.12%. %. The volatility of related hype on Nextage Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 67.70. About 82.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.3. Nextage Therapeutics last dividend was issued on the 9th of June 2003. The entity had 1:20 split on the 12th of April 2020. Assuming the 90 days trading horizon the next forecasted press release will be uncertain. Check out Nextage Therapeutics Basic Forecasting Models to cross-verify your projections.Nextage Therapeutics Related Hype Analysis
Having access to credible news sources related to Nextage Therapeutics' direct competition is more important than ever and may enhance your ability to predict Nextage Therapeutics' future price movements. Getting to know how Nextage Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nextage Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BCOM | B Communications | 0.00 | 0 per month | 1.54 | 0.12 | 4.90 | (3.10) | 16.14 | |
| ICL | ICL Israel Chemicals | 0.00 | 0 per month | 2.17 | (0.05) | 5.55 | (3.18) | 11.77 | |
| TSEM | Tower Semiconductor | 0.00 | 0 per month | 2.75 | 0.01 | 3.91 | (3.61) | 14.22 | |
| AMRK | Amir Marketing and | 0.00 | 0 per month | 1.47 | 0.06 | 3.78 | (2.75) | 13.42 | |
| RPAC | Rapac Communication Infrastructure | 0.00 | 0 per month | 1.54 | (0.08) | 2.33 | (2.73) | 8.23 | |
| SNCM | Suny Cellular Communication | 0.00 | 0 per month | 1.45 | 0.04 | 4.44 | (2.52) | 9.40 | |
| VRDS | Veridis Environment | 0.00 | 0 per month | 1.94 | 0.09 | 4.99 | (3.45) | 17.23 | |
| ONE | One Software Technologies | 0.00 | 0 per month | 2.23 | 0.10 | 3.91 | (3.61) | 9.96 |
Nextage Therapeutics Additional Predictive Modules
Most predictive techniques to examine Nextage price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nextage using various technical indicators. When you analyze Nextage charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Nextage Therapeutics Predictive Indicators
The successful prediction of Nextage Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Nextage Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Nextage Therapeutics based on analysis of Nextage Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Nextage Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nextage Therapeutics's related companies.
Story Coverage note for Nextage Therapeutics
The number of cover stories for Nextage Therapeutics depends on current market conditions and Nextage Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nextage Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nextage Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Nextage Therapeutics Short Properties
Nextage Therapeutics' future price predictability will typically decrease when Nextage Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Nextage Therapeutics often depends not only on the future outlook of the potential Nextage Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nextage Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.1 M | |
| Short Long Term Debt | 202 K |
Complementary Tools for Nextage Stock analysis
When running Nextage Therapeutics' price analysis, check to measure Nextage Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nextage Therapeutics is operating at the current time. Most of Nextage Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nextage Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nextage Therapeutics' price. Additionally, you may evaluate how the addition of Nextage Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |